DZ Bank’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $830M | Sell |
13,229,644
-5,311,049
| -29% | -$425M | 0.74% | 38 |
|
|
2025
Q4 | $1.77B | Buy |
18,540,693
+4,508,152
| +32% | +$442M | 1.53% | 14 |
|
|
2025
Q3 | $1.37B | Sell |
14,032,541
-2,582,988
| -16% | -$267M | 1.2% | 13 |
|
|
2025
Q2 | $1.78B | Sell |
16,615,529
-1,128,735
| -6% | -$114M | 1.78% | 7 |
|
|
2025
Q1 | $1.79B | Sell |
17,744,264
-4,568,703
| -20% | -$460M | 2% | 7 |
|
|
2024
Q4 | $1.99B | Buy |
22,312,967
+554,388
| +3% | +$48.8M | 2.02% | 9 |
|
|
2024
Q3 | $1.82B | Sell |
21,758,579
-526,223
| -2% | -$41.5M | 1.79% | 9 |
|
|
2024
Q2 | $1.72B | Buy |
22,284,802
+1,660,673
| +8% | +$122M | 1.76% | 12 |
|
|
2024
Q1 | $1.41B | Sell |
20,624,129
-508,589
| -2% | -$32.7M | 1.52% | 14 |
|
|
2023
Q4 | $1.22B | Sell |
21,132,718
-1,165,436
| -5% | -$62.2M | 1.52% | 14 |
|
|
2023
Q3 | $1.18B | Buy |
22,298,154
+806,030
| +4% | +$42.3M | 1.67% | 14 |
|
|
2023
Q2 | $1.16B | Sell |
21,492,124
-1,955,504
| -8% | -$102M | 1.75% | 12 |
|
|
2023
Q1 | $1.17B | Buy |
23,447,628
+53,775
| +0.2% | +$2.53M | 1.93% | 7 |
|
|
2022
Q4 | $1.08B | Buy |
23,393,853
+1,659,431
| +8% | +$71.9M | 1.89% | 10 |
|
|
2022
Q3 | $842M | Buy |
21,734,422
+928,278
| +4% | +$37.2M | 1.59% | 16 |
|
|
2022
Q2 | $775M | Buy |
20,806,144
+4,088,589
| +24% | +$166M | 1.4% | 18 |
|
|
2022
Q1 | $740M | Buy |
16,717,555
+6,837,140
| +69% | +$296M | 1.11% | 24 |
|
|
2021
Q4 | $425M | Sell |
9,880,415
-2,714,811
| -22% | -$114M | 0.6% | 45 |
|
|
2021
Q3 | $547M | Sell |
12,595,226
-2,799,968
| -18% | -$124M | 0.87% | 34 |
|
|
2021
Q2 | $658M | Buy |
15,395,194
+1,053,304
| +7% | +$44.3M | 1.07% | 28 |
|
|
2021
Q1 | $554M | Buy |
14,341,890
+6,727,273
| +88% | +$255M | 1.02% | 23 |
|
|
2020
Q4 | $271M | Buy |
7,614,617
+1,564,387
| +26% | +$56.4M | 0.57% | 51 |
|
|
2020
Q3 | $231M | Buy |
6,050,230
+2,576,952
| +74% | +$99.3M | 0.55% | 52 |
|
|
2020
Q2 | $122M | Sell |
3,473,278
-3,968,130
| -53% | -$143M | 0.34% | 68 |
|
|
2020
Q1 | $243M | Sell |
7,441,408
-4,662,665
| -39% | -$182M | 0.82% | 29 |
|
|
2019
Q4 | $545M | Buy |
12,104,073
+9,677
| +0.1% | +$405K | 1.43% | 15 |
|
|
2019
Q3 | $492M | Buy |
12,094,396
+450,403
| +4% | +$19.1M | 1.47% | 16 |
|
|
2019
Q2 | $500M | Buy |
11,643,993
+5,778,717
| +99% | +$222M | 1.55% | 17 |
|
|
2019
Q1 | $225M | Buy |
5,865,276
+3,028,077
| +107% | +$116M | 0.73% | 42 |
|
|
2018
Q4 | $98.4M | Buy |
2,837,199
+2,424,309
| +587% | +$87.9M | 0.38% | 73 |
|
|
2018
Q3 | $15.9M | Buy |
412,890
+6,400
| +2% | +$224K | 0.06% | 210 |
|
|
2018
Q2 | $13.3M | Buy |
406,490
+127,400
| +46% | +$3.84M | 0.05% | 235 |
|
|
2018
Q1 | $7.63M | Hold |
279,090
| – | – | 0.03% | 328 |
|
|
2017
Q4 | $6.92M | Sell |
279,090
-6,824
| -2% | -$188K | 0.03% | 323 |
|
|
2017
Q3 | $8.34M | Hold |
285,914
| – | – | 0.03% | 291 |
|
|
2017
Q2 | $7.93M | Buy |
285,914
+10,790
| +4% | +$286K | 0.04% | 278 |
|
|
2017
Q1 | $6.84M | Hold |
275,124
| – | – | 0.03% | 305 |
|
|
2016
Q4 | $5.95M | Buy |
+275,124
| New | +$6M | 0.03% | 306 |
|
Other funds holding BSX
VCM
VPM
DZ Bank's BSX Position: Q1 2026 in Review
DZ Bank reduced its Boston Scientific (BSX) stake by 29% in Q1 2026, selling an estimated $425M and leaving 13,229,644 shares worth $830M. The position accounts for 0.74% of the portfolio, ranked #38.
DZ Bank first reported a position in BSX in Q4 2016 and has held it in 38 quarters since. The position peaked at $1.99B in Q4 2024. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- DZ Bank held 13,229,644 shares of Boston Scientific worth $830M as of Q1 2026.
- DZ Bank sold 5,311,049 Boston Scientific shares in Q1 2026, an estimated $425M.
- Boston Scientific made up 0.74% of DZ Bank's portfolio in Q1 2026, its #38 holding.
- DZ Bank first reported a position in Boston Scientific in Q4 2016 and has held it in 38 quarters since.
- DZ Bank's Boston Scientific position peaked at $1.99B in Q4 2024.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on DZ Bank's 13F filing for Q1 2026, filed 15 May 2026.